GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Glaukos Corp (FRA:6GJ) » Definitions » Other Long Term Assets

Glaukos (FRA:6GJ) Other Long Term Assets : €19.6 Mil (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Glaukos Other Long Term Assets?

Glaukos's other long-term assets for the quarter that ended in Dec. 2023 was €19.6 Mil.

Glaukos's quarterly other long-term assets increased from Jun. 2023 (€16.7 Mil) to Sep. 2023 (€17.5 Mil) and increased from Sep. 2023 (€17.5 Mil) to Dec. 2023 (€19.6 Mil).

Glaukos's annual other long-term assets increased from Dec. 2021 (€16.4 Mil) to Dec. 2022 (€16.7 Mil) and increased from Dec. 2022 (€16.7 Mil) to Dec. 2023 (€19.6 Mil).


Glaukos Other Long Term Assets Historical Data

The historical data trend for Glaukos's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glaukos Other Long Term Assets Chart

Glaukos Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.48 13.79 16.39 16.70 19.56

Glaukos Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.79 16.75 17.48 19.56 22.59

Glaukos Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Glaukos (FRA:6GJ) Business Description

Traded in Other Exchanges
Address
One Glaukos Way, Aliso Viejo, CA, USA, 92656
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Glaukos (FRA:6GJ) Headlines

No Headlines